10-Q 1 y8624010q.htm
false 2024 --12-31 Q2 0001104038 0001104038 2024-01-01 2024-06-30 0001104038 vrme:CommonStockParValue0.001PerShareMember 2024-01-01 2024-06-30 0001104038 vrme:WarrantsToPurchaseCommonStockMember 2024-01-01 2024-06-30 0001104038 2024-08-06 0001104038 2024-06-30 0001104038 2023-12-31 0001104038 us-gaap:SeriesAPreferredStockMember 2024-06-30 0001104038 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001104038 us-gaap:SeriesBPreferredStockMember 2024-06-30 0001104038 us-gaap:SeriesBPreferredStockMember 2023-12-31 0001104038 2024-04-01 2024-06-30 0001104038 2023-04-01 2023-06-30 0001104038 2023-01-01 2023-06-30 0001104038 2022-12-31 0001104038 2023-06-30 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2023-03-31 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2023-03-31 0001104038 us-gaap:CommonStockMember 2023-03-31 0001104038 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001104038 vrme:TreasuryStocksMember 2023-03-31 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001104038 us-gaap:RetainedEarningsMember 2023-03-31 0001104038 2023-03-31 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2024-03-31 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2024-03-31 0001104038 us-gaap:CommonStockMember 2024-03-31 0001104038 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001104038 vrme:TreasuryStocksMember 2024-03-31 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001104038 us-gaap:RetainedEarningsMember 2024-03-31 0001104038 2024-03-31 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2022-12-31 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2022-12-31 0001104038 us-gaap:CommonStockMember 2022-12-31 0001104038 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001104038 vrme:TreasuryStocksMember 2022-12-31 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001104038 us-gaap:RetainedEarningsMember 2022-12-31 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2023-12-31 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2023-12-31 0001104038 us-gaap:CommonStockMember 2023-12-31 0001104038 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001104038 vrme:TreasuryStocksMember 2023-12-31 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001104038 us-gaap:RetainedEarningsMember 2023-12-31 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2023-04-01 2023-06-30 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2023-04-01 2023-06-30 0001104038 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001104038 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001104038 vrme:TreasuryStocksMember 2023-04-01 2023-06-30 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001104038 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2024-04-01 2024-06-30 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2024-04-01 2024-06-30 0001104038 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001104038 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001104038 vrme:TreasuryStocksMember 2024-04-01 2024-06-30 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001104038 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2023-01-01 2023-06-30 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2023-01-01 2023-06-30 0001104038 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001104038 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001104038 vrme:TreasuryStocksMember 2023-01-01 2023-06-30 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0001104038 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2024-01-01 2024-06-30 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2024-01-01 2024-06-30 0001104038 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001104038 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-06-30 0001104038 vrme:TreasuryStocksMember 2024-01-01 2024-06-30 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-06-30 0001104038 us-gaap:RetainedEarningsMember 2024-01-01 2024-06-30 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2023-06-30 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2023-06-30 0001104038 us-gaap:CommonStockMember 2023-06-30 0001104038 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001104038 vrme:TreasuryStocksMember 2023-06-30 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001104038 us-gaap:RetainedEarningsMember 2023-06-30 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2024-06-30 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2024-06-30 0001104038 us-gaap:CommonStockMember 2024-06-30 0001104038 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001104038 vrme:TreasuryStocksMember 2024-06-30 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001104038 us-gaap:RetainedEarningsMember 2024-06-30 0001104038 vrme:VerifyMeIncMember 2024-01-01 2024-06-30 0001104038 us-gaap:RestrictedStockMember 2024-04-01 2024-06-30 0001104038 us-gaap:RestrictedStockMember 2024-01-01 2024-06-30 0001104038 us-gaap:EmployeeStockOptionMember 2024-04-01 2024-06-30 0001104038 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-06-30 0001104038 us-gaap:WarrantMember 2024-04-01 2024-06-30 0001104038 us-gaap:WarrantMember 2024-01-01 2024-06-30 0001104038 vrme:ConversionConvertibleDebtMember 2024-04-01 2024-06-30 0001104038 vrme:ConversionConvertibleDebtMember 2024-01-01 2024-06-30 0001104038 us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0001104038 us-gaap:PreferredStockMember 2024-01-01 2024-06-30 0001104038 us-gaap:RestrictedStockMember 2023-04-01 2023-06-30 0001104038 us-gaap:RestrictedStockMember 2023-01-01 2023-06-30 0001104038 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0001104038 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001104038 us-gaap:WarrantMember 2023-04-01 2023-06-30 0001104038 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001104038 us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001104038 us-gaap:PreferredStockMember 2023-01-01 2023-06-30 0001104038 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001104038 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001104038 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-01-01 2024-06-30 0001104038 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-01-01 2024-06-30 0001104038 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0001104038 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0001104038 vrme:AuthenticationMember vrme:ProactiveServicesMember 2024-04-01 2024-06-30 0001104038 vrme:AuthenticationMember vrme:ProactiveServicesMember 2023-04-01 2023-06-30 0001104038 vrme:PrecisionLogisticsMember vrme:ProactiveServicesMember 2024-04-01 2024-06-30 0001104038 vrme:PrecisionLogisticsMember vrme:ProactiveServicesMember 2023-04-01 2023-06-30 0001104038 vrme:ProactiveServicesMember 2024-04-01 2024-06-30 0001104038 vrme:ProactiveServicesMember 2023-04-01 2023-06-30 0001104038 vrme:AuthenticationMember vrme:PremiumServicesMember 2024-04-01 2024-06-30 0001104038 vrme:AuthenticationMember vrme:PremiumServicesMember 2023-04-01 2023-06-30 0001104038 vrme:PrecisionLogisticsMember vrme:PremiumServicesMember 2024-04-01 2024-06-30 0001104038 vrme:PrecisionLogisticsMember vrme:PremiumServicesMember 2023-04-01 2023-06-30 0001104038 vrme:PremiumServicesMember 2024-04-01 2024-06-30 0001104038 vrme:PremiumServicesMember 2023-04-01 2023-06-30 0001104038 vrme:AuthenticationMember vrme:BrandProtectionServicesMember 2024-04-01 2024-06-30 0001104038 vrme:AuthenticationMember vrme:BrandProtectionServicesMember 2023-04-01 2023-06-30 0001104038 vrme:PrecisionLogisticsMember vrme:BrandProtectionServicesMember 2024-04-01 2024-06-30 0001104038 vrme:PrecisionLogisticsMember vrme:BrandProtectionServicesMember 2023-04-01 2023-06-30 0001104038 vrme:BrandProtectionServicesMember 2024-04-01 2024-06-30 0001104038 vrme:BrandProtectionServicesMember 2023-04-01 2023-06-30 0001104038 vrme:AuthenticationMember 2024-04-01 2024-06-30 0001104038 vrme:AuthenticationMember 2023-04-01 2023-06-30 0001104038 vrme:PrecisionLogisticsMember 2024-04-01 2024-06-30 0001104038 vrme:PrecisionLogisticsMember 2023-04-01 2023-06-30 0001104038 vrme:AuthenticationMember vrme:ProactiveServicesMember 2024-01-01 2024-06-30 0001104038 vrme:AuthenticationMember vrme:ProactiveServicesMember 2023-01-01 2023-06-30 0001104038 vrme:PrecisionLogisticsMember vrme:ProactiveServicesMember 2024-01-01 2024-06-30 0001104038 vrme:PrecisionLogisticsMember vrme:ProactiveServicesMember 2023-01-01 2023-06-30 0001104038 vrme:ProactiveServicesMember 2024-01-01 2024-06-30 0001104038 vrme:ProactiveServicesMember 2023-01-01 2023-06-30 0001104038 vrme:AuthenticationMember vrme:PremiumServicesMember 2024-01-01 2024-06-30 0001104038 vrme:AuthenticationMember vrme:PremiumServicesMember 2023-01-01 2023-06-30 0001104038 vrme:PrecisionLogisticsMember vrme:PremiumServicesMember 2024-01-01 2024-06-30 0001104038 vrme:PrecisionLogisticsMember vrme:PremiumServicesMember 2023-01-01 2023-06-30 0001104038 vrme:PremiumServicesMember 2024-01-01 2024-06-30 0001104038 vrme:PremiumServicesMember 2023-01-01 2023-06-30 0001104038 vrme:AuthenticationMember vrme:BrandProtectionServicesMember 2024-01-01 2024-06-30 0001104038 vrme:AuthenticationMember vrme:BrandProtectionServicesMember 2023-01-01 2023-06-30 0001104038 vrme:PrecisionLogisticsMember vrme:BrandProtectionServicesMember 2024-01-01 2024-06-30 0001104038 vrme:PrecisionLogisticsMember vrme:BrandProtectionServicesMember 2023-01-01 2023-06-30 0001104038 vrme:BrandProtectionServicesMember 2024-01-01 2024-06-30 0001104038 vrme:BrandProtectionServicesMember 2023-01-01 2023-06-30 0001104038 vrme:AuthenticationMember 2024-01-01 2024-06-30 0001104038 vrme:AuthenticationMember 2023-01-01 2023-06-30 0001104038 vrme:PrecisionLogisticsMember 2024-01-01 2024-06-30 0001104038 vrme:PrecisionLogisticsMember 2023-01-01 2023-06-30 0001104038 vrme:BusinessCombinationMember 2023-02-27 2023-03-01 0001104038 2023-02-27 2023-03-01 0001104038 us-gaap:RestrictedStockMember vrme:BusinessCombinationMember 2023-03-01 0001104038 2024-05-15 0001104038 vrme:TrustCodesGlobalLimitedMember 2023-03-01 0001104038 vrme:TrustCodesGlobalLimitedMember 2023-02-27 2023-03-01 0001104038 vrme:TrustCodesGlobalLimitedMember us-gaap:DevelopedTechnologyRightsMember 2023-03-01 0001104038 vrme:TrustCodesGlobalLimitedMember us-gaap:TrademarksMember 2023-03-01 0001104038 vrme:TrustCodesGlobalLimitedMember us-gaap:CustomerRelationshipsMember 2023-03-01 0001104038 vrme:AuthenticationMember 2023-12-31 0001104038 vrme:PrecisionLogisticsMember 2023-12-31 0001104038 vrme:AuthenticationMember 2024-06-30 0001104038 vrme:PrecisionLogisticsMember 2024-06-30 0001104038 us-gaap:TrademarksMember 2024-06-30 0001104038 vrme:CapitalizedSoftwareMember 2024-06-30 0001104038 us-gaap:CustomerRelationshipsMember 2024-06-30 0001104038 us-gaap:DevelopedTechnologyRightsMember 2024-06-30 0001104038 vrme:InternallyUsedSoftwareMember 2024-06-30 0001104038 us-gaap:NoncompeteAgreementsMember 2024-06-30 0001104038 vrme:DeferredImplementationMember 2024-06-30 0001104038 us-gaap:TrademarksMember 2023-12-31 0001104038 vrme:CapitalizedSoftwareMember 2023-12-31 0001104038 us-gaap:CustomerRelationshipsMember 2023-12-31 0001104038 us-gaap:DevelopedTechnologyRightsMember 2023-12-31 0001104038 vrme:InternallyUsedSoftwareMember 2023-12-31 0001104038 us-gaap:NoncompeteAgreementsMember 2023-12-31 0001104038 vrme:DeferredImplementationMember 2023-12-31 0001104038 us-gaap:PatentsMember 2024-06-30 0001104038 2024-03-01 2024-03-31 0001104038 2024-06-01 2024-06-30 0001104038 vrme:Plan2021Member 2024-04-01 2024-06-30 0001104038 vrme:Plan2021Member 2024-01-01 2024-06-30 0001104038 vrme:Plan2021Member 2023-04-01 2023-06-30 0001104038 vrme:Plan2021Member 2024-02-29 0001104038 2023-12-01 2023-12-31 0001104038 vrme:StockOptionsRestrictedStockandUnitsandOtherStockbasedAwardsMember vrme:OmnibusEquityCompensationPlan2013Member 2013-12-31 0001104038 srt:BoardOfDirectorsChairmanMember vrme:EquityIncentivePlan2017Member 2017-11-13 2017-11-14 0001104038 srt:BoardOfDirectorsChairmanMember vrme:EquityIncentivePlan2020Member 2020-08-09 2020-08-10 0001104038 srt:BoardOfDirectorsChairmanMember vrme:EquityIncentivePlan2020Member 2022-03-01 2022-03-28 0001104038 srt:BoardOfDirectorsChairmanMember vrme:EquityIncentivePlan2020Member 2023-04-01 2023-04-17 0001104038 srt:BoardOfDirectorsChairmanMember vrme:EquityIncentivePlan2020Member 2024-03-01 2024-03-18 0001104038 vrme:IncentiveStockOptionsMember 2024-01-01 2024-06-30 0001104038 vrme:IssuedUnderThe2020PlanMember 2024-01-01 2024-06-30 0001104038 us-gaap:StockOptionMember 2024-01-01 2024-06-30 0001104038 us-gaap:StockOptionMember 2023-01-01 2023-06-30 0001104038 us-gaap:RestrictedStockMember 2024-06-30 0001104038 vrme:RestrictedStockUnitsMember 2024-06-30 0001104038 vrme:RestrictedStockUnitsMember 2024-01-01 2024-06-30 0001104038 vrme:NonvestedStockOptionsMember 2024-06-30 0001104038 vrme:NonvestedStockOptionsMember 2024-01-01 2024-06-30 0001104038 us-gaap:EmployeeStockOptionMember 2023-12-31 0001104038 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-06-30 0001104038 us-gaap:EmployeeStockOptionMember 2024-06-30 0001104038 us-gaap:RestrictedStockMember 2023-12-31 0001104038 us-gaap:RestrictedStockMember 2024-01-01 2024-06-30 0001104038 vrme:RestrictedStockUnitsMember 2023-12-31 0001104038 vrme:NonvestedStockOptionsMember 2023-12-31 0001104038 2022-10-17 0001104038 2022-10-01 2022-10-17 0001104038 2023-08-01 2023-08-25 0001104038 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember vrme:OneCustomerMember 2024-04-01 2024-06-30 0001104038 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember vrme:OneCustomerMember 2023-04-01 2023-06-30 0001104038 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember vrme:OneCustomerMember 2024-01-01 2024-06-30 0001104038 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember vrme:OneCustomerMember 2023-01-01 2023-06-30 0001104038 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember vrme:OneCustomerMember 2024-01-01 2024-06-30 0001104038 vrme:TransportationCostMember us-gaap:ProductConcentrationRiskMember vrme:OneVendorMember 2024-04-01 2024-06-30 0001104038 vrme:TransportationCostMember us-gaap:ProductConcentrationRiskMember vrme:OneVendorMember 2024-01-01 2024-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 10-Q

 

 

(Mark one)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2024

 

OR

 

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                      to                     

 

Commission file number 001-39332  

 

 
VERIFYME, INC.
(Exact Name of Registrant as Specified in Its Charter)
 

 

Nevada   23-3023677

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

     

801 International Parkway, Fifth Floor

Lake Mary, FL 

  32746
(Address of Principal Executive Offices)   (Zip Code)
     
(585) 736-9400 
(Registrant’s Telephone Number, Including Area Code)

 

(Former Name, Former Address and Former Fiscal year, if Changed Since Last Report)

 

 

 

  
 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s)

Name of each exchange on which

Registered

Common Stock, par value $0.001 per share VRME The Nasdaq Capital Market
Warrants to Purchase Common Stock VRMEW The Nasdaq Capital Market

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes x     No o

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T  § 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes x    No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or, an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company,” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer o   Accelerated filer o
         
Non-accelerated filer x   Smaller reporting company  x
         
Emerging growth company  o      

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes o     No x 

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 10,384,698 shares of common stock outstanding at August 6, 2024.

 

 

 2 
 

  

PART I - FINANCIAL INFORMATION
     
ITEM 1. Financial Statements 4
Consolidated Balance Sheets (Unaudited) 4
Consolidated Statements of Operations (Unaudited) 6
Consolidated Statements of Comprehensive Loss (Unaudited) 7
Consolidated Statements of Cash Flows (Unaudited) 8
Consolidated Statements of Stockholders' Equity (Unaudited) 10
Notes to Consolidated Financial Statements (Unaudited) 12
ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 29
ITEM 3. Quantitative and Qualitative Disclosures about Market Risk 37
ITEM 4. Controls and Procedures 37
     
PART II - OTHER INFORMATION
ITEM 1. Legal Proceedings 38
ITEM 1A. Risk Factors 38
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 39
ITEM 3. Defaults Upon Senior Securities 39
ITEM 4. Mine Safety Disclosures 39
ITEM 5. Other Information 39
ITEM 6. Exhibits 40
SIGNATURES 41

 

 3 

 

PART I - FINANCIAL STATEMENTS

ITEM 1. 

 

VerifyMe, Inc.

Consolidated Balance Sheets

(In thousands, except share data)

           
   As of 
   June 30, 2024   December 31, 2023 
   (Unaudited)     
         
ASSETS          
           
CURRENT ASSETS          
Cash and cash equivalents including restricted cash  $2,900   $3,095 
Accounts receivable, net of allowance for credit loss reserve, $156 and $165 as of June 30, 2024 and December 31, 2023, respectively   1,214    3,017 
Unbilled revenue   751    1,282 
Prepaid expenses and other current assets   210    254 
Inventory   23    38 
TOTAL CURRENT ASSETS   5,098    7,686 
           
PROPERTY AND EQUIPMENT, NET  $184   $240 
           
RIGHT OF USE ASSET   378    468 
           
INTANGIBLE ASSETS, NET   6,539    6,927 
           
GOODWILL   5,334    5,384 
           
TOTAL ASSETS  $17,533   $20,705 
           
LIABILITIES AND STOCKHOLDERS' EQUITY          
           
CURRENT LIABILITIES          
Term note, current  $500   $500 
Accounts payable   1,331    3,310 
Other accrued expense   808    988 
Lease liability- current   165    170 
Contingent liability- current   123    173 
TOTAL CURRENT LIABILITIES   2,927    5,141 
           
LONG-TERM LIABILITIES          
Contingent liability, non-current  $401   $751 
Long-term lease liability   223    307 
Term note   625    875 
Convertible Note – related party   475    475 
Convertible Note   625    625 
TOTAL LIABILITIES  $5,276   $8,174 
           
STOCKHOLDERS' EQUITY          
Series A Convertible Preferred Stock, $.001 par value, 37,564,767 shares authorized; 0 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively   -    - 
           
Series B Convertible Preferred Stock, $.001 par value; 85 shares authorized; 0.85 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively   -    - 

 

 4 

 

Common stock, $0.001 par value; 675,000,000 authorized; 10,655,065 and 10,453,315 issued, 10,384,698 and 10,123,964 shares outstanding as of June 30, 2024 and December 31, 2023, respectively   11    10 
           
Additional paid in capital   95,504    95,031 
           
Treasury stock at cost; 270,367 and 329,351 shares at June 30, 2024 and December 31, 2023, respectively   (464)   (659)
           
Accumulated deficit   (82,748)   (81,849)
           
Accumulated other comprehensive loss   (46)   (2)
           
STOCKHOLDERS' EQUITY   12,257    12,531 
           
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY  $17,533   $20,705 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 5 

 

VerifyMe, Inc.

Consolidated Statements of Operations

(Unaudited)

(In thousands, except share data)

                     
   Three Months Ended   Six Months Ended 
   June 30, 2024   June 30, 2023   June 30, 2024   June 30, 2023 
                 
NET REVENUE  $5,352   $5,335   $11,111   $10,996 
                     
COST OF REVENUE(a)   3,262    3,749    6,761    7,889 
                     
GROSS PROFIT   2,090    1,586    4,350    3,107 
                     
OPERATING EXPENSES                    
Segment management and Technology(a)   1,517    1,251    2,860    2,356 
General and administrative (a)   894    836    2,015    2,249 
Research and development   5    10    60    18 
Sales and marketing (a)   210    527    598    1,026 
Total Operating expenses   2,626    2,624    5,533    5,649 
                     
LOSS BEFORE OTHER INCOME (EXPENSE)   (536)   (1,038)   (1,183)   (2,542)
                     
OTHER (EXPENSE) INCOME                    
Interest expenses, net   (42)   (46)   (80)   (88)
Unrealized gain (loss) on equity investment   -    30    -    (2)
Change in fair value of contingent consideration   232    172    364    172 
Other expense, net   -    -    -    (2)
TOTAL OTHER INCOME (EXPENSE), NET   190    156    284    80 
                    
NET LOSS  $(346)  $(882)  $(899)  $(2,462)
                     
LOSS PER SHARE                    
BASIC   (0.03)   (0.09)   (0.09)   (0.26)
DILUTED   (0.03)   (0.09)   (0.09)   (0.26)
                     
WEIGHTED AVERAGE COMMON SHARE OUTSTANDING                    
BASIC   10,238,717    9,765,452    10,156,081    9,614,183 
DILUTED   10,238,717    9,765,452    10,156,081    9,614,183 

 

(a)Includes share-based compensation of $239 thousand and $697 thousand for the three and six months ended June 30, 2024, respectively, and $315 thousand and $601 thousand for the three and six months ended June 30, 2023 respectively.  

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 6 

 

VerifyMe, Inc.

Consolidated Statements of Comprehensive Loss

(Unaudited)

(In thousands)

                     
   Three Months Ended   Six Months Ended 
   June 30, 2024   June 30, 2023   June 30, 2024   June 30, 2023 
NET LOSS  $(346)  $(882)  $(899)  $(2,462)
                     
Change in fair value of interest rate, Swap   2    2    5    1 
                     
Foreign currency translation adjustments   18    (46)   (49)   (48)
                     
Total Comprehensive Loss  $(326)  $(926)  $(943)  $(2,509)

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 7 

 

VerifyMe, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)

           
   Six months ended 
   June 30, 2024   June 30, 2023 
CASH FLOWS FROM OPERATING ACTIVITIES          
Net loss  $(899)  $(2,462)
Adjustments to reconcile net loss to net cash used in operating activities :          
Allowance for bad debt   9    4 
Stock based compensation   89    41 
Unrealized loss on equity investment   -    2 
Change in fair value of contingent consideration   (364)   (172)
Fair value of restricted stock awards and restricted stock units issued in exchange for services   608    560 
Loss on disposal of equipment   -    2 
Impairments   13    34 
Amortization and depreciation   599    540 
Unrealized loss on foreign currency transactions   30    10 
Changes in operating assets and liabilities:          
Accounts receivable   1,790    3,156 
Unbilled revenue   530    451 
Inventory   15    34 
Prepaid expenses and other current assets   47    46 
Accounts payable, other accrued expenses and net change in operating leases    (2,155)   (2,709)
Net cash provided by (used) in operating activities   312    (463)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Purchase of patents   (12)   (42)
Purchase of office equipment   (5)   (24)
Cash paid in business combination   -    (363)
Deferred implementation costs   -    (56)
Capitalized software costs   (174)   (373)
Net cash used in investing activities   (191)   (858)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Proceeds from line of credit   -    800 
Proceeds from SPP Plan   21    71 
Contingent consideration payments   (36)   - 
Tax withholding payments for employee stock-based compensation in exchange for shares surrendered   (47)   (3)
Increase in treasury shares (share repurchase program)   (1)   (10)
Repayment of debt and line of credit   (250)   (250)
           
Net cash (used in) provided by financing activities   (313)   608 
           
Effect of exchange rate changes on cash   (3)   (1)
           
NET DECREASE IN CASH AND CASH EQUIVALENTS   (195)   (714)
CASH AND CASH EQUIVALENTS INCLUDING RESTRICTED CASH- BEGINNING OF PERIOD   3,095    3,411 
CASH AND CASH EQUIVALENTS INCLUDING RESTRICTED CASH- END OF PERIOD  $2,900   $2,697 

 

 8 

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION        
Cash paid during the period for:        
Interest  $94   $68 
Income taxes  $-   $- 
           
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES          
Change in fair value of interest rate, swap  $5   $1 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 9 

 

VerifyMe, Inc.

Consolidated Statements of Stockholders' Equity

(Unaudited)

(In thousands, except share data)

 

                                                             
   Series A
Convertible
   Series B
Convertible
                                 
   Preferred   Preferred   Common       Treasury             
   Stock   Stock   Stock   Additional   Stock             
   Number of   Number of   Number of   Paid-In   Number of   Accumulated Other   Accumulated     
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Shares   Amount   Comprehensive Loss   Deficit   Total 
                                                 
Balance at March 31, 2023   -    -    0.85    -    9,348,914    10    93,790    348,075    (793)   (6)   (80,039)   12,962 
Restricted stock awards, net of shares
withheld for employee tax
   -    -    -    -    485,444    -    146    -    -    -    -    146 
Restricted Stock Units, net of shares withheld for employee tax   -    -    -    -    -    -    148    -    -    -    -    148 
Common stock issued in relation to Stock Purchase Plan   -    -    -    -    8,407    -    27    (407)   1    -    -    28 
Accumulated Other Comprehensive Loss   -    -    -    -    -    -    -    -    -    (44)   -    (44)
Net loss   -    -    -    -    -    -    -    -    -    -    (882)   (882)
Balance at June 30, 2023   -    -    0.85    -    9,842,765    10    94,111    347,668    (792)   (50)   (80,921)   12,358 

 

 

 

   Series A
Convertible
   Series B
Convertible
                                 
   Preferred   Preferred   Common       Treasury             
   Stock   Stock   Stock   Additional   Stock             
   Number of   Number of   Number of   Paid-In   Number of   Accumulated Other   Accumulated     
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Shares   Amount   Comprehensive Loss   Deficit   Total 
                                                 
Balance at March 31, 2024   -    -    0.85    -    10,176,603    10    95,438    308,462    (589)   (66)   (82,402)   12,391 
Restricted stock awards   -    -    -    -    140,000    1    127    -    -    -    -    128 
Restricted Stock Units, net of shares withheld for employee tax   -    -    -    -    38,095    -    (103)   (38,095)   125    -    -    22 
Common stock issued for services   -    -    -    -    30,000    -    42                        42 
Accumulated Other Comprehensive Income   -    -    -    -    -    -    -    -    -    20    -    20 
Net loss   -    -    -    -    -    -    -    -    -    -    (346)   (346)
Balance at June 30, 2024   -    -    0.85    -    10,384,698    11    95,504    270,367    (464)   (46)   (82,748)   12,257 

 

 10 

 

   Series A   Series B                                 
   Convertible   Convertible                                 
   Preferred   Preferred   Common       Treasury             
   Stock   Stock   Stock   Additional   Stock   Accumulated Other         
   Number of       Number of       Number of       Paid-In   Number of       Comprehensive   Accumulated     
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Shares   Amount   Loss   Deficit   Total 
Balance at December 31, 2022   -    -    0.85    -    8,951,035    10    92,987    389,967    (949)   (3)   (78,459)   13,586 
Restricted stock awards, net of shares withheld for employee tax   -    -    -    -    485,444    -    147    -    -    -    -    147 
Restricted stock units, net of shares withheld for employee tax   -    -    -    -    1,750    -    410    -    -    -    -    410 
Common stock issued in relation to Stock Purchase Plan   -    -    -    -    57,245    -    (58)   (48,500)   167    -    -    109 
Common stock issued in relation to Acquisition   -    -    -    -    353,492    -    625    -    -    -    -    625 
Repurchase of common stock   -    -    -    -    (6,201)   -    -    6,201    (10)   -    -    (10)
Accumulated other comprehensive loss   -    -    -    -    -    -    -    -    -    (47)   -    (47)
Net loss        -    -    -    -    -    -    -    -    -    (2,462)   (2,462)
Balance at June 30, 2023   -    -    0.85    -    9,842,765    10    94,111    347,668    (792)   (50)   (80,921)   12,358 

 

 

 

   Series A   Series B                                 
   Convertible   Convertible                                 
   Preferred   Preferred   Common       Treasury             
   Stock   Stock   Stock   Additional   Stock   Accumulated Other         
   Number of       Number of       Number of       Paid-In   Number of       Comprehensive   Accumulated     
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Shares   Amount   Loss   Deficit   Total 
Balance at December 31, 2023   -    -    0.85    -    10,123,964    10    95,031    329,351    (659)   (2)   (81,849)   12,531 
Restricted stock awards   -    -    -    -    140,000    1    275    -    -    -    -    276 
Restricted stock units, net of shares withheld for employee tax   -    -    -    -    39,845    -    160    (38,095)   125    -    -    285 
Common stock issued in relation to Stock Purchase Plan   -    -    -    -    21,889    -    (46)   (21,889)   71    -    -    25 
Common stock issued for services   -    -    -    -    60,000    -    84    -    -    -    -    84 
Repurchase of Common Stock   -    -    -    -    (1,000)   -    -    1,000    (1)   -    -    (1)
Accumulated other comprehensive loss   -    -    -    -    -    -    -    -    -    (44)   -    (44)
Net loss        -    -    -    -    -    -    -    -    -    (899)   (899)
Balance at June 30, 2024   -    -    0.85    -    10,384,698    11    95,504    270,367    (464)   (46)   (82,748)   12,257 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 11 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements (unaudited)

 

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of the Business

 

VerifyMe, Inc. (“VerifyMe”) was incorporated in the State of Nevada on November 10, 1999. VerifyMe, together with its subsidiaries, including Trust Codes Global Limited (“Trust Codes Global”) and PeriShip Global LLC (“PeriShip Global”), (together the “Company,” “we,” “us,” or “our”) is based in Lake Mary, Florida and its common stock, par value $0.001 per share, and warrants to purchase common stock are traded on The Nasdaq Capital Market (“Nasdaq”) under the trading symbols “VRME” and “VRMEW,” respectively.

 

VerifyMe, is a traceability and customer support services provider using specialized software and process technology. The Company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. Through our Precision Logistics segment, we provide a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, sort volumes, and traffic, delivered to customers via a secure portal. The portal provides real-time visibility into shipment transit and last-mile events which is supported by a service center. Through our Authentication segment our technologies enable brand owners to gather business intelligence through the supply chain, cross-sell products, detect counterfeit activities, monitor product diversion, and build brand loyalty utilizing our unique dynamic codes which are read by consumers with their smart phones. The Company’s activities are subject to significant risks and uncertainties. See the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in this report.

 

Reclassifications

 

Certain amounts presented for the three and six months ended June 30, 2023, reflect reclassifications made to conform to the presentation in our current reporting period. These reclassifications had no effect on the previously reported net loss.

 

Basis of Presentation

 

The accompanying unaudited interim consolidated financial statements (the “Interim Statements”) include the accounts of VerifyMe and its wholly owned subsidiaries PeriShip Global and Trust Codes Global. All significant intercompany balances and transactions have been eliminated upon consolidation. The consolidated financial statements have been prepared pursuant to the rules and regulations for reporting on Form 10-Q. Accordingly, certain information and disclosures required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements are not included herein. The Interim Statements should be read in conjunction with the financial statements and notes thereto included in the Company’s latest Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission (the “SEC”) on March 29, 2024.  The accompanying Interim Statements are unaudited; however, in the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The interim results for the three and six months ended June 30, 2024, are not necessarily indicative of the results to be expected for the year ending December 31, 2024, or for any future interim periods.

 

Restricted Cash

 

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts in the consolidated statements of cash flows (dollars in thousands):

         
   As of 
   June 30, 2024   December 31,2023 
         
Cash and cash equivalents  $2,900   $3,032 
Restricted cash   -    63 
Total cash and cash equivalents including restricted cash  $2,900   $3,095 

 

The Company classifies cash and cash equivalents that are restricted from operating use for the next twelve months as restricted cash. No cash was subject to restriction as of June 30, 2024. As of December 31, 2023, the Company held $63 thousand subject to restrictions.

 

 12 

 

Segment Reporting

 

Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the chief operating decision maker, or decision-making group, in deciding the method by which to allocate resources and assess performance. The Company has two reportable segments, namely, (i) Precision Logistics and (ii) Authentication. See Note 11 - Segment Reporting, for further discussion of the Company’s segment reporting structure. 

 

Foreign Currency Translation

 

The functional currency of our New Zealand operations is the local currency, New Zealand dollar (NZD). The translation of the foreign currency into U.S. dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for revenue and expense accounts using the weighted average exchange rates prevailing during the year. The unrealized gains and losses resulting from such translation are included as a component of comprehensive income. Translation gains and losses arising from currency exchange rate fluctuations on transactions denominated in a currency other than the local functional currency are included in “General and administrative” on our Consolidated Statements of Operations. The foreign currency transaction for the three and six months ended June 30, 2024, was a $16 thousand gain and $46 thousand loss, respectively. The foreign currency transaction losses for the three and six months ended June 30, 2023, were immaterial.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

 

Recent Accounting Pronouncements

 

In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, Segment Reporting (Topic 280): “Improvements to Reportable Segment Disclosures”, which requires public entities with a single reportable segment to provide all the disclosures required by this standard and all existing segment disclosures in Topic 280 on an interim and annual basis, including new requirements to disclose significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”) and included within the reported measure(s) of a segment's profit or loss, the amount and composition of any other segment items, the title and position of the CODM, and how the CODM uses the reported measure(s) of a segment's profit or loss to assess performance and decide how to allocate resources. The guidance is effective for annual periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024, applied retrospectively with early adoption permitted. The Company adopted the new standard beginning January 1, 2024. Note 11 – Segment Reporting has been updated to reflect the new disclosure requirements and certain amounts have been reclassified in the Consolidated Statement of Operations. There is no other impact of adoption of this standard on the Company’s consolidated financial statements and disclosures.

 

Fair Value of Financial Instruments

 

The Company’s financial instruments consist of accounts receivable, unbilled revenue, accounts payable, notes payable and accrued expenses, contingent consideration and long-term derivative assets or liabilities. The carrying value of accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short maturities.  The Company believes the carrying amount of its notes payable approximates fair value based on rates and other terms currently available to the Company for similar debt instruments.

 

The Company follows FASB ASC 820, “Fair Value Measurements and Disclosures,” and applies it to all assets and liabilities that are being measured and reported on a fair value basis. The statement requires that assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:

 

Level 1: Quoted market prices in active markets for identical assets or liabilities

 

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data

 

Level 3: Unobservable inputs that are not corroborated by market data

 

The level in the fair value within which a fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.

 

 13 

 

The following table presents the Company’s financial instruments that are measured and recorded at fair value on the Company’s balance sheets on a recurring basis, and their level within the fair value hierarchy as of June 30, 2024 and December 31, 2023.

 

Amounts in Thousands ('000)

         
   Derivative Asset   Contingent Consideration 
   (Level 2)   (Level 3) 
         
Balance as of December 31, 2023  $4   $(924)
           
Change in fair value of Contingent Consideration   -    364 
           
Payments   -    36 
           
Change in fair value to interest rate, SWAP, recognized in other comprehensive loss   5    - 
           
Balance at June 30, 2024  $9   $(524)

 

Revenue Recognition

 

The Company accounts for revenues according to Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers” which establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the entity's contracts to provide goods or services to customers.

 

 14 

 

The Company applies the following five steps, separated by reportable segments, in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements.

 

·identify the contract with a customer;
·identify the performance obligations in the contract;
·determine the transaction price;
·allocate the transaction price to performance obligations in the contract; and
·recognize revenue as the performance obligation is satisfied.

 

For more detailed information about reportable segments, see Note 11 – Segment reporting. The Company generally considers completion of an agreement, or Statement of Work (“SOW”) and/or purchase order as a customer contract, provided collection is considered probable.

 

Precision Logistics

 

Our Precision Logistics segment consists of two service lines, Proactive and Premium. Under our Proactive service line, clients pay us directly for carrier service coupled with our proactive logistics service. Terms typically range 7 days and no longer than 30 days. The Company has determined it is the principal and recognizes shipment fees in gross revenue. Under our Premium service line, we provide complete white-glove shipping monitoring and predictive analytics services. This service includes customer web portal access, weather monitoring, temperature control, full service center support and last mile resolution. Payment terms are typically 30-45 days.

 

Under both service lines in our Precision Logistics segment, our performance obligation is met, and revenue is recognized, when the packages are delivered. The transaction fees consist of fixed consideration made up of amounts contractually billed to the customer. There are no variable considerations in the transaction fee, in either service line.

 

Authentication

 

Our Authentication segment primarily consists of our brand protection service line which consists of a custom suite of products that offer clients traceability and brand solutions. Terms typically range between 30 and 90 days. Our performance obligation is met, and revenue is recognized, when our products are shipped or delivered depending on the specific agreement with the customer. The transaction fee is made up of fixed consideration based on the related purchase order or agreement. Warranties and other variable considerations are analyzed by the Company, in terms of historical warranties, current economic trends, and changes in customer demand, and have been determined to be insignificant in the three and six months ended June 30, 2024.

 

Goodwill

 

Goodwill represents the excess of purchase price over the fair value of net assets acquired in business combinations. Pursuant to ASC 350, the Company tests goodwill for impairment on an annual basis in the fourth quarter, or between annual tests, in certain circumstances. Under authoritative guidance, the Company first assesses qualitative factors to determine whether it was necessary to perform the quantitative goodwill impairment test. The assessment considers factors such as, but not limited to, macroeconomic conditions, data showing other companies in the industry and our share price. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Events or changes in circumstances which could trigger an impairment review include macroeconomic conditions, industry and market conditions, cost factors, overall financial performance, other entity specific events and sustained decrease in share price.

 

 15 

 

Basic and Diluted Net Loss per Share of Common Stock

 

The Company follows FASB ASC 260, “Earnings Per Share,” when reporting earnings per share resulting in the presentation of basic and diluted earnings per share.  Because the Company reported a net loss for each of the periods presented, common stock equivalents, including preferred stock, stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and diluted loss per share were the same. 

 

For the three and six months ended June 30, 2024, and 2023, there were shares potentially issuable, that could dilute basic earnings per share in the future that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive to the Company’s losses during the periods presented. For the three and six months ended June 30, 2024, there were approximately 8,208,000 anti-dilutive shares consisting of 2,177,000 unvested performance restricted stock units, restricted stock units, and restricted stock awards, 301,000 shares issuable upon exercise of stock options, 4,629,000 shares issuable upon exercise of warrants, 957,000 shares issuable upon conversion of convertible debt, and 144,000 shares issuable upon conversion of preferred stock. For the three and six months ended June 30, 2023, there were approximately 7,108,000 anti-dilutive shares consisting of 1,998,000 unvested performance restricted stock units, restricted stock units, restricted stock awards and options under the stock purchase plan, 337,000 shares issuable upon exercise of stock options, 4,629,000 shares issuable upon exercise of warrants, and 144,000 shares issuable upon conversion of preferred stock.

 

 16 

 

Stock-Based Compensation

 

We account for stock-based compensation under the provisions of FASB ASC 718, “Compensation—Stock Compensation”, which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. We estimate the fair value of stock options on the date of grant using the Black-Scholes model. The assumptions used in the Black-Scholes option pricing model include risk-free interest rates, expected volatility and expected life of the stock options. Changes in these assumptions can materially affect estimates of fair value stock-based compensation, and the compensation expense recorded in future periods. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line method. For performance restricted stock units with stock price appreciation targets (see Note 6 – Stock Options, Restricted Stock and Warrants), we applied a lattice approach that incorporated a Monte Carlo simulation, which involved random iterations that took different future price paths over the restricted stock unit’s contractual life based on the appropriate probability distributions (which are based on commonly applied Black Scholes inputs). The fair value was determined by taking the average of the grant date fair values under each Monte Carlo simulation trial. We recognize compensation expense on a straight-line basis over the performance period and there is no ongoing adjustment or reversal based on actual achievement during the period.

 

We account for stock-based compensation awards to non-employees in accordance with ASU No. 2018-07, Compensation – Stock Based Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting , which aligns accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes previous guidance for equity-based payments to nonemployees under Subtopic 505-50, “Equity – Equity-Based Payments to Non-Employees”.  

 

All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Non-employee equity-based payments are recorded as an expense over the service period, as if we had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity-based payments will be re-measured, and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity-based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity-based payments are fully vested or the service completed. 

 

NOTE 2 – REVENUE

 

Revenue by Category

 

The following series of tables present our revenue disaggregated by various categories (dollars in thousands).

                         
   Authentication   Precision Logistics   Consolidated 
Revenue  Three Months Ended
June 30,
   Three Months Ended
June 30,
   Three Months Ended
June 30,
 
   2024   2023   2024   2023   2024   2023 
                         
Proactive services  $-   $-   $3,945   $4,200   $3,945   $4,200 
Premium services   -    -    1,299    1,014    1,299    1,014 
Brand protection services   108    121    -    -    108    121 
   $108   $121   $5,244   $5,214   $5,352   $5,335 

 

                         
   Authentication   Precision Logistics   Consolidated 
Revenue  Six Months Ended
June 30,
   Six Months Ended
June 30,
   Six Months Ended
June 30,
 
   2024   2023   2024   2023   2024   2023 
                         
Proactive services  $-   $-   $8,170   $8,704   $8,170   $8,704 
Premium services   -    -    2,688    1,924    2,688    1,924 
Brand protection services   253    368    -    -    253    368 
   $253   $368   $10,858   $10,628   $11,111   $10,996 

 

 17 

 

Contract Balances 

 

The timing of revenue recognition, billings and cash collections results in unbilled revenue (contract assets) and deferred revenue (contract liabilities) on the consolidated balance sheets. Amounts charged to our clients become billable according to the contract terms, which usually consider the delivery completion. Unbilled amounts will generally be billed and collected within 30 days but typically no longer than 60 days. When we advance bill clients prior to the work being performed, generally, such amounts will be earned and recognized in revenue within twelve months. These assets and liabilities are reported on the consolidated balance sheets on a contract-by-contract basis at the end of each reporting period. Changes in the contract asset and liability balances during the six-month period ended June 30, 2024, were not materially impacted by any other factors.

 

Applying the practical expedient in ASC Topic 606, we recognize the incremental costs of obtaining contracts (i.e. sales commissions) as an expense when incurred if the amortization period of the assets that we otherwise would have recognized is one year or less. As of June 30, 2024, we did not have any capitalized sales commissions.

 

For all periods presented, contract liabilities were not significant. 

 

The following table provides information about contract assets from contracts with customers: 

         
   Contract Asset 
   June 30, 
In Thousands  2024   2023 
Beginning balance, January 1  $1,282   $1,185 
Contract asset additions   4,329    3,326 
Reclassification to accounts receivable, billed to customers   (4,860)   (3,777)
Ending balance (1)  $751   $734 

______________

(1)Included within "Unbilled revenue" on the accompanying Consolidated Balance sheets.

 

 18 

  

NOTE 3 – BUSINESS COMBINATIONS

 

Trust Codes Global Limited

 

On March 1, 2023, we acquired, through Trust Codes Global, the business and certain assets of Trust Codes Limited (“Trust Codes”), specializing in brand protection, anti-counterfeiting, and consumer engagement technology with an expertise in the food and agriculture industry. Trust Codes Global uses unique QR codes or IoT, coupled with GS1 standards to deliver cloud-based brand protection based on a unique per-item digital identity to protect brand and product authenticity, increase data visualization of a product through the end to end supply chain, and creates a data-drive engine to inform and educate consumers of the product. The Company accounted for the transaction as an acquisition of a business under ASC 805 – Business Combination. The purchase price was approximately $1.0 million which consisted of $0.36 million in cash paid at closing and 353,492 shares of common stock of the Company, representing $0.65 million in stock consideration. In addition, the purchase agreement requires consideration contingent upon the achievement of earnings targets during a five-year period subsequent to the closing of the acquisition. The earn-out consideration is estimated at $1.1 million at the acquisition date, however the maximum amount of the payment is unlimited. The goodwill recognized is due to the expected synergies from combining the operations of the acquiree with the Company. All of the goodwill recorded for financial statement purposes is deductible for tax purposes. The Company incurred $278 thousand in relation to acquisition related costs which have been included in General and administrative in the six months ended June 30, 2023, in the accompanying Consolidated Statements of Operations. Trust Codes Global is included in the Authentication segment and the results of its operations have been included in the consolidated financial statements beginning March 1, 2023. The pro-forma financial information for Trust Codes is immaterial to our results of operations and impractical to provide.

 

The following table summarizes the purchase price allocation for the acquisition (dollars in thousands).

        
Cash  $363    
Fair value of contingent consideration   1,125    
Stock (issuance of 353,492 shares of common stock) (a)   625    
Total purchase price  $2,113    
         
        Amortization
        Period
Purchase price allocation:        
Prepaid expenses  $25    
Property and Equipment, net   18    
ROU Asset   171    
Developed Technology   485   8 years
Trade Names/Trademarks   148   18 years
Customer Relationships   68   10 years
Goodwill   1,383    
Accounts payable and other accrued expenses   (14)   
Current lease liability   (63)   
Long term lease liability   (108)   
   $2,113    

 

(a)Stock issued was calculated based on the 15 day volume-weighted average price (“VWAP”) through February 28, 2023 calculated at $1.8388.

 

Contingent Consideration

 

ASC Topic 805 requires that contingent consideration to be recognized at fair value on the acquisition date and be re-measured each reporting period with subsequent adjustments recognized in the consolidated statement of operations. We estimate the fair value of contingent consideration liabilities using an appropriate valuation methodology, typically either an income-based approach or a simulation model, such as the Monte Carlo model, depending on the structure of the contingent consideration arrangement. Contingent consideration is valued using significant inputs that are not observable in the market which are defined as Level 3 inputs pursuant to fair value measurement accounting. We believe our estimates and assumptions are reasonable; however, there is significant judgment involved. At each reporting date, the contingent consideration obligation is revalued to estimated fair value, and changes in fair value subsequent to the acquisitions are reflected in income or expense in the consolidated statements of operations, and could cause a material impact to, and volatility in, our results. Changes in the fair value of contingent consideration obligations may result from changes in discount periods and rates and changes in the timing and amount of revenue and/or earnings projections.

 

 19 

 

As of June 30, 2024, contingent consideration presented as current liability totaled $123 thousand. As of June 30, 2024, we also had accrued long term contingent consideration totaling $401 thousand related to the acquisition of Trust Codes on the consolidated balance sheets and represents the portion of contingent consideration estimated to be payable greater than twelve months from the balance sheet date. On May 15, 2024, a payment of $36 thousand was paid for contingent consideration.

 

NOTE 4 – INTANGIBLE ASSETS AND GOODWILL

 

Goodwill

 

Goodwill represents costs in excess of values assigned to the underlying net assets of acquired businesses. Intangible assets acquired are recorded at estimated fair value. Goodwill is deemed to have an indefinite life and is not amortized but is tested for impairment annually, and at any time when events suggest an impairment more likely than not has occurred. We test goodwill at the reporting unit level.

 

ASC Topic 350, “Intangibles - Goodwill and Other” (“ASC Topic 350”), permits an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test.  Under ASC Topic 350, an entity is not required to perform a quantitative goodwill impairment test for a reporting unit if it is more likely than not that its fair value is greater than its carrying amount. A reporting unit is an operating segment, or one level below an operating segment, as defined by U.S. GAAP.

 

Determining the fair value of a reporting unit is judgmental in nature and involves the use of significant estimates and assumptions. These estimates and assumptions include revenue growth rates and operating margins used to calculate projected future cash flows, risk-adjusted discount rates, future economic and market conditions and determination of appropriate market comparables. We base our fair value estimates on assumptions we believe to be reasonable but are unpredictable and inherently uncertain. Actual future results may differ from those estimates. The timing and frequency of our goodwill impairment tests are based on an ongoing assessment of events and circumstances that would indicate a possible impairment. We will continue to monitor our goodwill and intangible assets for impairment and conduct formal tests when impairment indicators are present.

 

Each of our two reportable segments represents an operating segment under ASC Topic 280, Segment Reporting. We test our goodwill at the reporting unit level, or one level below an operating segment, under ASC Topic 350, “Intangibles - Goodwill and Other”. We determined that we have two reporting units for purposes of goodwill impairment testing, which represent our two reportable business segments, as discussed below.

 

Changes in the carrying amount of goodwill by reportable business segment for the six months ended June 30, 2024, were as follows (in thousands):

                
   Authentication   Precision Logistics   Total 
Net book value at               
January 1, 2024  $1,396   $3,988   $5,384 
                
2024 Activity               
Foreign currency translation   (50)   -    (50)
Net book value at               
June 30, 2024  $1,346   $3,988   $5,334 

 

 20 

 

Intangible Assets Subject to Amortization

 

Our intangible assets include amounts recognized in connection with patents and trademarks, capitalized software and acquisitions, including customer relationships, tradenames, developed technology and non-compete agreements. Intangible assets are initially valued at fair market value using generally accepted valuation methods appropriate for the type of intangible asset. Amortization is recognized on a straight-line basis over the estimated useful life of the intangible assets. Intangible assets with definite lives are reviewed for impairment if indicators of impairment arise. Except for goodwill, we do not have any intangible assets with indefinite useful lives.

 

Intangible assets with finite lives are subject to amortization over their estimated useful lives. The primary assets included in this category and their respective balances were as follows (in thousands):

                    
June 30, 2024  Gross Carrying Amount   Accumulated Amortization   Net Carrying Amount   Weighted
Average
Remaining
Useful
Life (Years)
 
Patents and Trademarks  $1,766   $(394)  $1,372    12 
Capitalized Software   161    (125)   36    2 
Customer Relationships   1,905    (412)   1,493    8 
Developed Technology   3,614    (1,227)   2,387    5 
Internally Used Software   1,087    (108)   979    6 
Non-Compete Agreement   191    (84)   107    3 
Deferred Implementation   198    (33)   165    9 
Total Intangible Assets  $8,922   $(2,383)  $6,539      
December 31, 2023                    
Patents and Trademarks  $2,002   $(564)  $1,438    13 
Capitalized Software   161    (109)   52    2 
Customer Relationships   1,908    (317)   1,591    9 
Developed Technology   3,632    (938)   2,694    5 
Internally Used Software   914    (62)   852    6 
Non-Compete Agreement   191    (65)   126    3 
Deferred Implementation   198    (24)   174    9 
Total Intangible Assets  $9,006   $(2,079)  $6,927      

 

Amortization expense for intangible assets was $540 thousand and $495 thousand for the six months ended June 30, 2024, and 2023, respectively. During the six months ended June 30, 2024, the Company impaired certain assets related to its Patents by $13 thousand, to bring the gross carrying amount related to these assets to zero, as these technologies are no longer in use.

 

Patents and Trademarks

 

As of June 30, 2024, our current patent and trademark portfolios consist of eight granted U.S. patents and two granted European patents (one validated in four countries of France, Germany, United Kingdom, and Italy and one validated in three countries of France, Germany and United Kingdom), three pending U.S. and foreign patent applications, twenty-three registered U.S. trademarks, two EU trademark registrations, one Colombian trademark registration, one Australian trademark registration, one Japanese trademark registration, one Mexican trademark registration, one Singaporean trademark registration, two UK trademark registrations, seven NZ trademark registration, one OAPI (African Intellectual Property Organization) trademark registration, and one pending US and one foreign trademark application in Nigeria. The Company abandoned one patent during the six months ended June 30, 2024.

 

The Company expects to record amortization expense of intangible assets over the next 5 years and thereafter as follows (in thousands):

  
Fiscal Year ending December 31,  
2024 (six months remaining) $572
2025  1,109
2026  1,104
2027  1,070
2028  696
Thereafter  1,988
Total $6,539

 

 21 

 

NOTE 5 – STOCKHOLDERS’ EQUITY

 

The Company expensed $127 thousand and $275 thousand related to restricted stock awards for the three and six months ended June 30, 2024, respectively. The Company expensed $147 thousand and $148 thousand related to restricted stock awards for the three and six months ended June 30, 2023, respectively.

 

The Company expensed $69 thousand and $333 thousand related to restricted stock units for the three and six months ended June 30, 2024, and $149 thousand and $412 thousand related to restricted stock units for the three and six months ended June 30, 2023.

 

During the six months ended June 30, 2024, the Company issued 1,750 shares of common stock upon vesting of restricted stock units, and 38,095 shares of common stock from treasury shares, net of common stock withheld for taxes.

 

On March 31, 2024, the Company issued 30,000 of restricted common stock, vesting immediately, with a value of $42 thousand, for consulting services. On June 30, 2024, the Company issued an additional 30,000 of restricted common stock, vesting immediately, with a value of $42 thousand, for consulting services.

  

Non-Qualified Stock Purchase Plan

 

On June 10, 2021, the stockholders of the Company approved a non-qualified stock purchase plan (the “2021 Plan”). The 2021 Plan provides eligible participants, including employees, directors and consultants of the Company, the opportunity to purchase shares of the Company’s common stock thereby increasing their interest in the Company’s continued success. The maximum number of common stock reserved and available for issuance under the 2021 Plan is 500,000 shares. The purchase price of shares of common stock acquired pursuant to the exercise of an option will be the lesser of 85% of the fair market value of a share (a) on the enrollment date, and (b) on the exercise date. The 2021 Plan is not intended to qualify as an employee stock purchase plan under Section 423 of the Internal Revenue Code of 1986, as amended (the “Code”). The Company applied FASB ASC 718, “Compensation-Stock Compensation” and estimated the fair value using the Black-Scholes model, as the 2021 Plan is considered compensatory. In relation to the 2021 Plan the Company expensed $0 and $4 thousand for the three and six months ended June 30, 2024, respectively. During the six months ended June 30, 2024 the Company received $21 thousand in proceeds related to the 2021 Plan. The Company has currently suspended new offering periods under the 2021 Plan.

 

Shares Held in Treasury

 

As of June 30, 2024, and December 31, 2023, the Company had 270,367 and 329,351 shares, respectively, held in treasury with a value of approximately $464 thousand and $659 thousand, respectively.  

 

On February 29, 2024, seven participants exercised their option under the Company’s non-qualified stock purchase plan, and as a result, 21,889 shares were issued from treasury, with an exercise price of $0.97 per share.

 

Shares Repurchase Program

 

In December 2023, the Company’s Board of Directors approved a new share repurchase program to allow the Company to spend up to $0.5 million to repurchase shares of its common stock so long as the price per share does not exceed $1.00 until December 14, 2024. During the six months ended June 30, 2024, the Company repurchased 1,000 shares of common stock for $1 thousand under the Company’s current program. 

 

NOTE 6 – STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS

 

During 2013, the Company adopted the 2013 Omnibus Equity Compensation Plan (the “2013 Plan”). Under the 2013 Plan, the Company is authorized to grant awards of stock options, restricted stock, restricted stock units and other stock-based awards up to an aggregate of 400,000 shares of common stock.  The 2013 Plan is intended to permit certain stock options granted to employees under the 2013 Plan to qualify as incentive stock options.  All options granted under the 2013 Plan, which are not intended to qualify as incentive stock options are deemed to be non-qualified stock options.  

 

On November 14, 2017, the Executive Committee of the Company’s Board of Directors adopted the 2017 Equity Incentive Plan (the “2017 Plan”) which covered the potential issuance of 260,000 shares of common stock. The 2017 Plan provided that directors, officers, employees, and consultants of the Company were eligible to receive equity incentives under the 2017 Plan at the discretion of the Board or the Board’s Compensation Committee.

 

 22 

 

On August 10, 2020, the Company’s Board of Directors adopted the 2020 Equity Incentive Plan (the “2020 Plan”), subject to stockholder approval, which authorizes the potential issuance of up to 1,069,110 shares of common stock. On September 30, 2020, the Company’s stockholders approved the 2020 Plan, and upon such approval the 2020 Plan became effective and the 2017 Plan was terminated. Shares of common stock underlying existing awards under the 2017 Plan may become available for issuance pursuant to the terms of the 2020 Plan under certain circumstances. Employees and non-employee directors of the Company or its affiliates, and other individuals who perform services for the Company or any of its affiliates, are eligible to receive awards under the 2020 Plan at the discretion of the Board of Directors or the Board’s Compensation Committee.

 

On March 28, 2022, the Company’s Board of Directors adopted the First Amendment to the 2020 Plan, subject to stockholder approval, which increased the shares authorized for potential issuance under the 2020 Plan to 2,069,100 shares of common stock and extended the term of the 2020 Plan to June 9, 2023. On June 9, 2022, the Company’s stockholders approved the First Amendment to the 2020 Plan. On April 17, 2023, the Company’s Board of Directors adopted the Second Amendment to the 2020 Plan, subject to stockholder approval, which increased the shares authorized for potential issuance under the 2020 Plan to 3,069,100 shares of common stock and extended the term of the 2020 Plan to June 6, 2033. On June 6, 2023, the Company’s stockholders approved the Second Amendment to the 2020 Plan. On March 18, 2024, the Company’s Board of Directors adopted the Third Amendment to the 2020 Plan, subject to stockholder approval, which increased the shares authorized for potential issuance under the 2020 Plan to 4,069,100 shares of common stock and extended the term of the 2020 Plan to June 4, 2033. On June 4, 2024, the Company’s stockholders approved the Third Amendment to the 2020 Plan.

 

The 2020 Plan, as amended, is administered by the Compensation Committee which determines the persons to whom awards will be granted, the number of awards to be granted and the specific terms of each grant, including the vesting thereof, subject to the provisions of the plan.

 

In connection with incentive stock options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company). The aggregate fair market value (determined at the time of the grant) of stock with respect to which incentive stock options are exercisable for the first time by any individual during any calendar year (under all plans of the Company and its affiliates) shall not exceed $100 thousand, and the options in excess of $100 thousand shall be deemed to be non-qualified stock options, including prices, duration, transferability and limitations on exercise. The maximum number of shares of common stock that may be issued under the 2020 Plan pursuant to incentive stock options may not exceed, in the aggregate, 1,000,000.

 

The Company has issued non-qualified stock options pursuant to contractual agreements with non-employees. Options granted under the agreements are expensed when the related service or product is provided. Determining the appropriate fair value of stock-based awards requires the input of subjective assumptions. The Company uses the Black-Scholes option pricing model to value its stock option awards. The assumptions used in calculating the fair value represent management’s best estimates and involve inherent uncertainties and judgements.

 

 

Stock Options

 

The following table summarizes the activities for the Company’s stock options as of June 30, 2024:

                     
   Options Outstanding 
           Weighted -     
           Average     
           Remaining   Aggregate 
       Weighted-   Contractual   Intrinsic 
   Number of   Average   Term   Value 
   Shares   Exercise Price   (in years)   (in thousands)(1) 
Balance as of December 31, 2023   301,471   $4.56           
                     
Granted   -    -           
                     
Forfeited/Cancelled/Expired   (471)  $212.50           
                     
Balance as of June 30, 2024   301,000   $4.24           
                     
Exercisable as of June 30, 2024   301,000   $4.24    0.7   $- 

 

(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period. 

 

 23 

 

As of June 30, 2024, the Company had no unvested stock options.

 

During the six months ended June 30, 2024, and 2023, the Company expensed $0 thousand, with respect to options.

 

As of June 30, 2024, there was $0 unrecognized compensation cost related to outstanding stock options.

 

Restricted Stock Awards and Restricted Stock Units

 

The following table summarizes the unvested restricted stock awards as of June 30, 2024:

           
       Weighted - 
       Average 
   Number of   Grant 
   Award Shares   Date Fair Value 
         
Unvested at December 31, 2023   416,669    1.44 
           
Granted   140,000    1.60 
           
Vested   (416,669)   1.44 
           
Balance at June 30, 2024   140,000   $1.60 

 

As of June 30, 2024, total unrecognized share-based compensation cost related to unvested restricted stock awards is $209 thousand, which is expected to be recognized over a weighted-average period of less than one year.

 

The following table summarizes the unvested time based restricted stock units as of June 30, 2024: 

           
       Weighted - 
       Average 
   Number of   Grant 
   Unit Shares   Date Fair Value 
Unvested at December 31, 2023   371,253    1.32 
           
Granted   35,000    1.60 
           
Vested   (70,527)   1.33 
           
Forfeited   (25,334)   1.23 
           
Balance at June 30, 2024   310,392   $1.34 

 

As of June 30, 2024, total unrecognized share-based compensation cost related to unvested restricted stock units was $206 thousand, which is expected to be recognized over a weighted-average period of 1.2 years.

 

 24 

 

The following table summarizes the unvested performance restricted stock units as of June 30, 2024:

           
       Weighted - 
       Average 
   Number of   Number of 
   Unit Shares   Unit Shares 
Unvested at December 31, 2023   1,438,760    1.51 
           
Granted   480,000    1.12 
           
Forfeited/Cancelled   (192,100)   1.78 
           
Balance at June 30, 2024   1,726,660   $1.37 

 

For restricted stock units with stock price appreciation targets, we applied a lattice approach that incorporated a Monte Carlo simulation, which involved random iterations that took different future price paths over the restricted stock unit’s contractual life based on the appropriate probability distributions (which are based on commonly applied Black Scholes inputs). The fair value of each grant was determined by taking the average of the grant date fair values under each Monte Carlo simulation trial. We recognize compensation expense on a straight-line basis over the derived service period and there is no ongoing adjustment or reversal based on actual achievement during the period.

 

As of June 30, 2024, total unrecognized share-based compensation cost related to unvested performance restricted stock units was $1,162 thousand, which is expected to be recognized over a weighted-average period of 1.4 years.

 

Warrants

 

The following table summarizes the activities for the Company’s warrants as of June 30, 2024:

                     
   Number of
Warrant Shares
  

Weighted-

Average

Exercise

Price

  

Weighted -

Average

Remaining

Contractual

Term

(in years)

  

Aggregate

Intrinsic

Value

(in thousands)(1)

 
Balance as of December 31, 2023   4,628,586   $4.13           
                     
Granted   -    -           
                     
Expired   -    -           
                     
Balance as of June 30, 2024   4,628,586   $4.13    1.8      
                     
Exercisable as of June 30, 2024   4,628,586   $4.13    1.8   $- 

 

(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $1.41 for our common stock on June 30, 2024.

 

NOTE 7—DEBT

 

PeriShip Global is a party to a debt facility with PNC Bank, National Association (the “PNC Facility”). The PNC Facility includes a $1 million revolving line of credit (the “RLOC”) with a term of one-year which expires in September 2024. The RLOC has no scheduled payments of principal until maturity, and bears interest per annum at a rate equal to the sum of Daily SOFR plus 2.85% with monthly interest payments. The PNC Facility also includes a four-year term note (the “Term Note”) for $2 million which matures in September of 2026 and requires equal quarterly payments of principal and interest. The Term Note incurs interest per annum at a rate equal to the sum of Daily SOFR plus 3.1%.  The RLOC and Term Note are guaranteed by VerifyMe and secured by the assets of PeriShip Global and VerifyMe.